|
|
|
|
|
|
|
|
Table of Contents
How Should We Define Value in Cancer Care? Listen to the Audio Podcast
Scott Ramsey, M.D., Ph.D., Adam Schickedanz,
Beyond Costs and Benefits: Understanding How Patients Make Health Care Decisions
Peter A. Ubel, M.D.
Therapy for Advanced Stage Cancer: What Do Patients Want and Expect? A Patient Advocate's Perspective
Robert L. Erwin, M.S.
The Role of the U.S. Food and Drug Administration Review Process: Clinical Trial Endpoints in Oncology
Amy E. McKee, M.D.
What Constitutes Reasonable Evidence of Efficacy and Effectiveness to Guide Oncology Treatment Decisions?
Daniel Sargent, Ph.D.
Drug Pricing and Value in Oncology
Patricia M. Danzon, Ph.D ., Erin Taylor
The Responsibility to Pay for Cancer Treatments: A Health Insurer's View of Value
Lee N. Newcomer, M.D.
Ethical and Value Issues in Insurance Coverage for Cancer Treatment
Dan W. Brock, Ph.D.
Ethical Issues in Patient–Physician Communication About Therapy for Cancer: Professional Responsibilities of the Oncologist
Neil S. Wenger, Paul M. Vespa
Rewarding Value Creation to Promote Innovation in Oncology: The Importance of Considering the Global Product Life Cycle
Louis P. Garrison, Jr., Ph.D.
Uncertainty in Assessing Value of Oncology Treatments
C. Daniel Mullins, Russ Montgomery, Sean Tunis, M.D.
Concrete Options and Ideas for Increasing Value in Oncology Care: The View from One Trench
Thomas J. Smith, M.D, Bruce E. Hillner
Of Value: A Discussion of Cost, Communication, and Evidence to Improve Cancer Care
Adam Schickedanz
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.